Scientific Programme

Sunday | Monday | Tuesday | Wednesday  

ECIO 2017 Preliminary Programme (PDF download 570 KB)

 

Sunday, April 23

   
  08:30-10:00
  Clinical Focus Session
CF 101 Colorectal cancer patients – the challenge
   
  Moderators: A. Cervantes (Valencia/ES), A. Gangi (Strasbourg/FR)
   
101.1
 
101.2
 
101.3
 
101.4
101.5
 
101.6
 
Demographics and need for treatment
A. Cervantes (Valencia/ES)
Treatment strategies according to the new ESMO guidelines
D. Arnold (Lisbon/PT)
Who is the ideal candidate for liver surgery?
to be announced
Invited scientific paper
Local ablation in oligometastatic disease
A. Gillams (London/UK)
Intra-arterial therapies in advanced metastases
P.L. Pereira (Heilbronn/DE)
   
   
  10:30-12:00
  Clinical Focus Session
CF 201 Immunotherapy for cancer
   
  Moderators: J.-F.H. Geschwind (New Haven, CT/US), P. Sarobe (Pamplona/ES)
   
201.1
 
201.2
 
201.3
 
201.4
 
201.5
 
Cancer and immune reaction
J.J. Lasarte (Pamplona/ES)
Immunoscore: is it more relevant than TNM?
J. Rodríguez (Pamplona/ES)
Checkpoint inhibitors
M. Fuchs (Munich/DE)
Tumour exosomes – determination of organotropic metastases
B. Costa-Silva (Lisbon/PT)
IO and immunotherapy in cancer
J.P. Erinjeri (New York, NY/US)
   
   
  10:30-12:00
  Clinical Focus Session
CF 202 Colorectal cancer and IO: where is the evidence?
   
  Moderator: P. Gibbs (Melbourne, VIC/AU)
   
202.1
 
202.2
 
202.3
 
202.4
 
202.5
 
CLOCC trial in detail
O.M. van Delden (Amsterdam/NL)
Evidence for surgery as a curative treatment
A. Denys (Lausanne/CH)
SIRFLOX trial in detail
P. Gibbs (Melbourne, VIC/AU)
Does progression-free survival translate into overall survival?
R. Sharma (London/UK)
Evidence in endpoints for IO in CRC mets
R. Salem (Chicago, IL/US)
   
   
  10:30-12:00
  Hands-on Device Training
TA-HDT 1 Tumour ablation – Radiofrequency
   
  Please click here for further details.
   
   
  13:00-14:30
  Satellite Symposia
   
   
  15:00-16:30
  Multidisciplinary Tumour Board
MTB 401 CRC metastases – beyond the guidelines
   
  Co-ordinator: T.K. Helmberger (Munich/DE)
   
  Panellists: D.J. Breen (Southampton/UK), A. Cervantes (Valencia/ES),
T. de Baère (Villejuif/FR), C.R. Ferrone (Boston, MA/US)
   
   
  15:00-16:30
  Technical Focus Session
TF 402 Cutting-edge developments
   
  Moderators: K. Malagari (Athens/GR), J. Ricke (Magdeburg/DE)
   
402.1
 
402.2
 
402.3
 
402.4
402.5
 
402.6
 
Drug-eluting particles
R. Duran (Lausanne/CH)
Thermal ablation
L. Crocetti (Pisa/IT)
Radioembolisation
M. van den Bosch (Utrecht/NL)
Invited scientific paper
Intratumoural immunotherapy and viral therapy
L. Tselikas (Villejuif/FR)
Immunotherapy plus ablation or DEB-TACE
B.J. Wood (Bethesda, MD/US)
   
   
  15:00-16:30
  Hands-on Device Training
TA-HDT 2 Tumour ablation – Radiofrequency
   
  Please click here for further details.
   
   
  17:00-18:30
  Clinical Focus Session
CF 501 Follow the colorectal cancer patients: quality and efficacy
   
  Moderators: A. Adam (London/UK), B. Gebauer (Berlin/DE)
   
501.1
 
501.2
 
501.3
 
501.4
 
501.5
 
What are the guidelines?
R. Vera (Pamplona/ES)
Does expensive and short-term imaging follow-up affect the outcome?
R.G.H. Beets-Tan (Amsterdam/NL)
PET-CT: a critical review
N. Schäfer (Lausanne/CH)
PRO, PCO and PREM – what do they tell us?
P. Reimer (Karlsruhe/DE)
Changing healthcare systems: what are convincing outcome measures?
I. Durand-Zaleski (Paris/FR)
   
   
  17:00-18:30
  Clinical Focus Session
CF 502 Getting IO into practice
   
  Moderators: J. Lammer (Vienna/AT), R.A. Morgan (London/UK)
   
502.1
 
502.2
 
502.3
 
502.4
 
502.5
 
Curriculum in IO
P.P. Rao (Dombivli/IN)
How to increase patient referral
T.F. Jakobs (Munich/DE)
Patient pathway in IO
J. Ricke (Magdeburg/DE)
Interaction with other disciplines
J.I. Bilbao (Pamplona/ES)
How do I promote IO services to my administration?
R.-T. Hoffmann (Dresden/DE)
   
   
  18:30-19:00
  Satellite Symposia
   

 

TOP
 

Monday, April 24

   
  07:45-08:15
  Satellite Symposia
   
   
  08:30-10:00
  Clinical Focus Session
CF 801 Lung metastases
   
  Moderators: A. Gillams (London/UK), U. Martens (Heilbronn/DE)
   
801.1
 
801.2
 
801.3
801.4
 
801.5
 
801.6
Rationale for local treatment – does it help patients?
I. Gil-Bazo (Pamplona/ES)
Resection – current status and evidence
T. Treasure (London/UK)
Invited scientific paper
SBRT – current status and evidence
L.M. Kenny (Brisbane, QLD/AU)
Thermal ablation – current status and evidence
T. de Baère (Villejuif/FR)
Round-table discussion
   
   
  08:30-10:00
  Clinical Focus Session
CF 802 Understanding tumour biology
   
  Moderators: P. Gibbs (Melbourne, VIC/AU), N. Goldberg (Jerusalem/IL)
   
802.1
 
802.2
 
802.3
 
802.4
 
802.5
 
Hypoxia and anoxia – friend or enemy?
B.J. Wood (Bethesda, MD/US)
IO procedures inducing tumour spread
C.T. Sofocleous (New York, NY/US)
Post-ablation inflammation and immune reactions – the bad
N. Goldberg (Jerusalem/IL)
Post-ablation inflammation and immune reactions – the good
M.H.M.G.M. den Brok (Nijmegen/NL)
Combined locoregional and systemic immunotherapy
L. Tselikas (Villejuif/FR)
   
   
  10:30-11:30
HL 901 Honorary Lecture
   
  Moderators: J.I. Bilbao (Pamplona/ES), E. Brountzos (Athens/GR)
   
901.1
 
 
Metastatic colorectal cancer and percutaneous thermal ablation:
a happy marriage?
J. Palussière (Bordeaux/FR)
   
   
  10:30-12:00
  Hands-on Device Training
TA-HDT 3 Tumour ablation – Microwave
   
  Please click here for further details.
   
   
  11:30-12:00
  Paper Session
PS 902 The best IO papers of 2016
   
  Moderators: J.I. Bilbao (Pamplona/ES), E. Brountzos (Athens/GR)
   
   
  13:00-14:30
  Satellite Symposia
   
   
  15:00-16:30
  Multidisciplinary Tumour Board
MTB 1101 Lung tumours – beyond the guidelines
   
  Co-ordinator: J. Palussière (Bordeaux/FR)
   
  Panellists: J. Aristu (Pamplona/ES), A. Gillams (London/UK),
J. Jougon (Pessac/FR), U. Martens (Heilbronn/DE)
   
   
  15:00-16:30
  Clinical Focus Session
CF 1102 IO in HCC: early and intermediate
   
  Moderators: R. Golfieri (Bologna/IT), B. Sangro (Pamplona/ES)
   
1102.1
 
1102.2
 
1102.3
 
1102.4
 
1102.5
 
From Barcelona to Hong Kong: the HCC classifications
B. Sangro (Pamplona/ES)
What to do when on the waiting list for transplantation
V. Mazzaferro (Milan/IT)
Local ablation in early stage: do we compete with surgery?
L. Crocetti (Pisa/IT)
Intermediate stage: is there room for radioembolisation?
R. Salem (Chicago, IL/US)
Intermediate stage: what are the indications for combined therapy?
T.F. Jakobs (Munich/DE)
   
   
  15:00-16:30
  Hands-on Device Training
TA-HDT 4 Tumour ablation – Microwave
   
  Please click here for further details.
   
   
  17:00-18:30
  Clinical Focus Session
CF 1201 IO in HCC: what's new?
   
  Moderators: V. Mazzaferro (Milan/IT), J. Urbano (Madrid/ES)
   
1201.1
 
1201.2
 
1201.3
 
1201.4
 
1201.5
 
1201.6
 
1201.7
 
Current status of classifying HCC and tailoring therapy: an update
J.-F.H. Geschwind (New Haven, CT/US)
New drugs in advanced HCC
B. Sangro (Pamplona/ES)
Bland embolisation vs. drug-eluting beads: the evidence
K. Malagari (Athens/GR)
RF vs. microwave in tumours up to 4 cm: the evidence
A. Denys (Lausanne/CH)
Cryoablation vs. RF
P.B. Shyn (Boston, MA/US)
SARAH trial
V. Vilgrain (Clichy/FR)
Idarubicin TACE
B. Guiu (Montpellier/FR)
   
   
  17:00-18:30
  Clinical Focus Session
CF 1202 Primary lung cancer
   
  Moderators: G. Bastarrika (Pamplona/ES), J. Palussière (Bordeaux/FR)
   
1202.1
 
1202.2
 
 
1202.3
1202.4
 
1202.5
 
1202.6
 
An update of systemic therapy of NSCLC
U. Martens (Heilbronn/DE)
Surgery, SBRT, local ablation: an appraisal of the pre- and post-treatment
lung function
E. Quoix (Strasbourg/FR)
Invited scientific paper
SBRT
J. Aristu (Pamplona/ES)
Local ablation
X. Buy (Bordeaux/FR)
Imaging follow-up of SBRT and ablation
R.D. Suh (Los Angeles, CA/US)
   
   
  18:30-19:00
  Satellite Symposia
   

TOP

 

Tuesday, April 25

   
  07:45-08:15
  Satellite Symposia
   
   
  08:30-10:00
  Clinical Focus Session
CF 1501 Breast cancer patients – the IO add-on
   
  Moderators: E. Aranda (Córdoba/ES), F. Orsi (Milan/IT)
   
1501.1
 
1501.2
 
1501.3
 
1501.4
1501.5
 
1501.6
 
Demographics and need for treatment
A. Urrutikoetxea (San Sebastián/ES)
Local treatment in metastatic breast cancer: the oncologist's perspective
J.-E. Kurtz (Strasbourg/FR)
Ablation of breast tumours
J. Palussière (Bordeaux/FR)
Invited scientific paper
IO in metastatic liver disease
F. Orsi (Milan/IT)
IO in metastatic bone disease
D.K. Filippiadis (Athens/GR)
   
   
  08:30-10:00
  Video Learning Session
VL 1502 How I do it – lung, kidney, bone
   
  Moderators: X. Serrés (Barcelona/ES)
Commentator: D.J. Breen (Southampton/UK)
   
1502.1
 
1502.2
 
1502.3
 
1502.4
 
Lung cryoablation
F. Deschamps (Villejuif/FR)
Kidney microwave ablation
J.L. Hinshaw (Madison, WI/US)
Bone consolidation
J. Garnon (Strasbourg/FR)
Thyroid radiofrequency ablation
F. Stacul (Trieste/IT)
   
   
  10:30-12:00
  Clinical Focus Session
CF 1601 MSK tumours beyond the spine
   
  Moderators: M.R. Callstrom (Rochester, MN/US), A.D. Kelekis (Athens/GR)
   
1601.1
 
1601.2
 
1601.3
1601.4
 
1601.5
 
1601.6
 
Bone consolidation in cancer patients: biomechanical and surgical
P.J. Papagelopoulos (Athens/GR)
Indications and limits of SBRT
S. Myrehaug (Toronto, ON/CA)
Invited scientific paper
Ablation and consolidation
R.-T. Hoffmann (Dresden/DE)
Management of benign bone tumours excluding osteoid osteoma
J. Jennings (St. Louis, MO/US)
Treatment options for soft tissue tumours
X. Buy (Bordeaux/FR)
   
   
  10:30-12:00
  Clinical Focus Session
CF 1602 Complication management
   
  Moderators: P. Reimer (Karlsruhe/DE), O.M. van Delden (Amsterdam/NL)
   
1602.1
 
1602.2
 
1602.3
 
1602.4
 
1602.5
 
1602.6
 
Liver thermal ablation
L. Solbiati (Rozzano/IT)
TACE
Y. Arai (Tokyo/JP)
Radioembolisation
B. Peynircioglu (Ankara/TR)
Kidney cryoablation
D.J. Breen (Southampton/UK)
Lung ablation
R.D. Suh (Los Angeles, CA/US)
Bone ablation
J. Garnon (Strasbourg/FR)
   
   
  10:30-12:00
  Hands-on Device Training
TA-HDT 5 Tumour ablation – Alternative techniques and image guidance
   
  Please click here for further details.
   
   
  13:00-14:30
  Satellite Symposia
   
   
  15:00-16:30
  Clinical Focus Session
CF 1801 Genomics in cancer
   
  Moderators: B. Costa-Silva (Lisbon/PT), R. Lencioni (Miami, FL/US)
   
1801.1
 
1801.2
 
1801.3
 
1801.4
 
1801.5
 
Genomics – a general concept?
R.B. Corcoran (Boston, MA/US)
Is genomics changing the percutaneous biopsy business?
G. Frija (Paris/FR)
Radiomics in MRI
D. Bonekamp (Heidelberg/DE)
Radiomics – new markers in PET-CT
N. Schäfer (Lausanne/CH)
Iomics – what could it mean?
R. Lencioni (Miami, FL/US)
   
   
  15:00-16:30
  Video Learning Session
VL 1802 How I do it – liver
   
  Moderator: A. Denys (Lausanne/CH)
Commentator: P.E. Huppert (Darmstadt/DE)
   
1802.1
 
1802.2
 
1802.3
 
1802.4
 
1802.5
 
Complex liver thermal ablation
P. Chevallier (Nice/FR)
Liver DEB-TACE
R. Golfieri (Bologna/IT)
Liver balloon TACE
T. de Baère (Villejuif/FR)
Liver radioembolisation
P. Reimer (Karlsruhe/DE)
Portal vein and hepatic vein embolisation
R. Duran (Lausanne/CH)
   
   
  17:00-18:30
  Clinical Focus Session
CF 1901 Spinal tumours
   
  Moderators: A. Gangi (Strasbourg/FR), J.W. Jennings (Saint Louis, MO/US)
   
1901.1
 
1901.2
 
1901.3
1901.4
 
1901.5
 
1901.6
 
Spinal surgery in cancer patients
J.-P. Steib (Strasbourg/FR)
Indications and limits of SBRT
L.M. Kenny (Brisbane, QLD/AU)
Invited scientific paper
Ablation and augmentation
J. Jennings (St. Louis, MO/US)
Management of benign tumours
A.D. Kelekis (Athens/GR)
The role of embolisation
L. Hechelhammer (St. Gallen/CH)
   
   
  17:00-18:30
  Clinical Focus Session
CF 1902 Promoting IO evidence
   
  Moderators: L. Donoso (Barcelona/ES), P.L. Pereira (Heilbronn/DE)
   
1902.1
 
1902.2
 
1902.3
 
1902.4
 
1902.5
 
CIRT
J.I. Bilbao (Pamplona/ES)
CIREL
P.L. Pereira (Heilbronn/DE)
Overview ongoing studies
V. Vilgrain (Clichy/FR)
How to bring a product to market?
N.T. Lange (Bonn/DE)
The value of registries vs. randomised trials
G.J. Poston (Liverpool/UK)
   
   
  18:30-19:00
  Satellite Symposia
   

TOP

 

Wednesday, April 26

   
  08:30-10:00
  Clinical Focus Session
CF 2101 Kidney tumours
   
  Moderators: J.C. Durack (New York, NY/US), D.K. Filippiadis (Athens/GR)
   
2101.1
 
2101.2
 
2101.3
 
2101.4
 
2101.5
 
Demographics and need for treatment
J.E. Robles (Pamplona/ES)
Evidence-based nephron-sparing surgery
B.W. Lagerveld (Amsterdam/NL)
Evidence-based ablation vs. resection outcomes
D.J. Breen (Southampton/UK)
Palliative intervention in metastatic renal tumours
M.R. Callstrom (Rochester, MN/US)
The CIRSE SOP paper on RCC (cT1a)
M.E. Krokidis (Cambridge/UK)
   
   
  08:30-10:00
  Clinical Focus Session
CF 2102 Recipes for general patient management
   
  Moderators: P.E. Bize (Genolier/CH), F. Orsi (Milan/IT)
   
2102.1
 
2102.2
 
2102.3
 
2102.4
 
2102.5
 
2102.6
 
Assessing the patient's general condition
M. Fuchs (Munich/DE)
Analgosedation vs. ITN
R. Bale (Innsbruck/AT)
Peri-interventional pain management
A. Vari (Rome/IT)
Peri-interventional antibiotics
G. Maleux (Leuven/BE)
Anticoagulation and anti-aggregants: how to deal with them
J.A. Páramo (Pamplona/ES)
Postembolisation syndrome management
B. Gebauer (Berlin/DE)
   
   
  10:00-10:45
  Satellite Symposium
   
   
  11:15-12:45
MM 2201 Morbidity & Mortality Conference
   
  Co-ordinators: M. Burrel (Barcelona/ES), P. Chevallier (Nice/FR)
   

TOP